LeMaitre Vascular, Inc.
LMAT · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $220 | $193 | $162 | $154 |
| % Growth | 13.6% | 19.7% | 4.7% | – |
| Cost of Goods Sold | $69 | $66 | $57 | $53 |
| Gross Profit | $151 | $127 | $105 | $101 |
| % Margin | 68.6% | 65.7% | 64.9% | 65.7% |
| R&D Expenses | $16 | $17 | $13 | $12 |
| G&A Expenses | $36 | $32 | $29 | $26 |
| SG&A Expenses | $83 | $73 | $62 | $53 |
| Sales & Mktg Exp. | $47 | $41 | $33 | $28 |
| Other Operating Expenses | $0 | $0 | $3 | $0 |
| Operating Expenses | $99 | $90 | $78 | $65 |
| Operating Income | $52 | $37 | $27 | $36 |
| % Margin | 23.8% | 19% | 16.6% | 23.6% |
| Other Income/Exp. Net | $5 | $3 | $1 | -$2 |
| Pre-Tax Income | $57 | $39 | $27 | $34 |
| Tax Expense | $13 | $9 | $7 | $7 |
| Net Income | $44 | $30 | $21 | $27 |
| % Margin | 20% | 15.6% | 12.8% | 17.4% |
| EPS | 1.96 | 1.36 | 0.94 | 1.27 |
| % Growth | 44.1% | 44.7% | -26% | – |
| EPS Diluted | 1.93 | 1.34 | 0.93 | 1.25 |
| Weighted Avg Shares Out | 22 | 22 | 22 | 21 |
| Weighted Avg Shares Out Dil | 23 | 22 | 22 | 21 |
| Supplemental Information | – | – | – | – |
| Interest Income | $5 | $3 | $1 | $0 |
| Interest Expense | $0 | $0 | $0 | $2 |
| Depreciation & Amortization | $10 | $10 | $9 | $9 |
| EBITDA | $67 | $49 | $37 | $46 |
| % Margin | 30.4% | 25.3% | 22.8% | 29.8% |